Total Voting Rights
Fusion Antibodies plc has announced its total voting rights, stating that as of January 30, 2026, the company's issued share capital consists of 125,021,878 ordinary shares of 4 pence each, with each share carrying one voting right. The company holds no shares in treasury, meaning the total number of voting rights available to shareholders is 125,021,878, which will serve as the denominator for FCA Disclosure Guidance and Transparency Rules calculations.
Select text to share a quote on X · sign in to keep highlights & notes in your FAB notes
Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announces that the issued share capital of the Company at the date of this announcement comprises 125,021,878 ordinary shares of 4 pence each with one voting right per share ("Ordinary Shares"). The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company is 125,021,878.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.